Antibiotics may Offer Promising Treatment for Form of Dementia

Fight dementia: Use of antibiotics called aminoglycosides could be a promising treatment for the form of dementia, reveals a new study.

Taking a class of antibiotics could hold the key to treat a form of dementia, reports a new study. The findings of the study are published in the journal Human Molecular Genetics.//

A team of researchers at the University of Kentucky's College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.

New Genetic Clues to Early-onset Form of Dementia Discovered
Identifying the downstream effects of the MAPT gene mutation could help identify new treatment targets for frontotemporal dementia, Alzheimer's disease and other tau-related illnesses, including Parkinson's disease.

‘A class of antibiotics called aminoglycosides can open up a therapeutic avenue for frontotemporal dementia treatment.’
Read More..

Results of their proof of concept study, which was a collaborative effort between UK's Department of Molecular and Cellular Biochemistry and the University of California San Francisco's Department of Pathology.

Frontotemporal dementia is the most common type of early onset dementia. It typically begins between ages 40 and 65 and affects the frontal and temporal lobes of the brain, which leads to behavior changes, difficulty speaking and writing, and memory deterioration.

A subgroup of patients with frontotemporal dementia have a specific genetic mutation that prevents brain cells from making a protein called progranulin. Although progranulin is not widely understood, its absence is linked to the disease.

Frontotemporal Dementia is Linked to Changes in Immune Function
Recent studies have indicated that inflammation and autoimmunity in the central nervous system and in peripheral blood may be linked to Frontotemporal dementia (FTD)

A group led by Haining Zhu, a professor in UK's Department of Molecular and Cellular Biochemistry, discovered that after aminoglycoside antibiotics were added to neuronal cells with this mutation, the cells started making the full-length progranulin protein by skipping the mutation.

"These patients' brain cells have a mutation that prevents progranulin from being made. The team found that by adding a small antibiotic molecule to the cells, they could 'trick' the cellular machinery into making it," said Matthew Gentry, a co-author of the study and the Antonio S. Turco Endowed Professor in the Department of Molecular and Cellular Biochemistry.

Global Efforts Needed to Control Rising Incidence of Dementia
Nearly a third of old age dementia can be prevented and physicians and policymakers alike should address modifiable risk factors and enforce policies that help prevent the decline of brain function.

The researchers found two specific aminoglycoside antibiotics - Gentamicin and G418 - were both effective in fixing the mutation and making the functional progranulin protein. After adding Gentamicin or G418 molecules to the affected cells, the progranulin protein level was recovered up to about 50 to 60%.

These results could be promising to drug development. Currently, there are no effective therapies for any type of dementia.

Dementia Risk Calculator
Dementia Risk Calculator is a tool to find out the risk of dementia among people over the age of 65.It also provides diet tips on Dementia.

After this preclinical proof of concept study, the next step is to study the antibiotics' effects on mice with the mutation that causes frontotemporal dementia, Zhu says. Another focus is to possibly develop new compounds from Gentamicin and G418 that could be safer and more effective. Although Gentamicin is an FDA-approved medication, its clinical usage is limited as it is associated with a number of adverse side effects.

"If we can get the right resources and physician to work with, we could potentially repurpose this drug. This is an early stage of the study, but it provides an important proof of concept that these aminoglycoside antibiotics or their derivatives can be a therapeutic avenue for frontotemporal dementia," said Zhu.

Source-Eurekalert